<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Perm Medical Journal</journal-id><journal-title-group><journal-title xml:lang="en">Perm Medical Journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Пермский медицинский журнал (сетевое издание "Perm medical journal")</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0136-1449</issn><issn publication-format="electronic">2687-1408</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">110826</article-id><article-id pub-id-type="doi">10.17816/pmj394144-154</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Preventive and social medicine</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Профилактическая и социальная медицина</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Gender features of malignant neoplasms associated with human papillo-mavirus in St. Petersburg</article-title><trans-title-group xml:lang="ru"><trans-title>Гендерные особенности злокачественных новообразований, ассоциированных с вирусом папилломы человека, в Санкт-Петербурге</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lyalina</surname><given-names>L. V.</given-names></name><name xml:lang="ru"><surname>Лялина</surname><given-names>Л. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Professor, Head of Laboratory of Epidemiology of Infectious and Non-Infectious Diseases</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор, заведующая лабораторией эпидемиологии инфекционных и неинфекционных заболеваний</p></bio><email>lyalina@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kholopov</surname><given-names>D. V.</given-names></name><name xml:lang="ru"><surname>Холопов</surname><given-names>Д. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>graduate student</p></bio><bio xml:lang="ru"><p>аспирант</p></bio><email>lyalina@pasteurorg.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khizha</surname><given-names>V. V.</given-names></name><name xml:lang="ru"><surname>Хижа</surname><given-names>В. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Head of Department of Medical Statistics of Tumor Diseases</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, начальник отдела медицинской статистики опухолевых заболеваний</p></bio><email>lyalina@pasteurorg.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kasatkin</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Касаткин</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Candidate of Medical Sciences, Head Doctor</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, главный врач</p></bio><email>lyalina@pasteurorg.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Topuzov</surname><given-names>Е. Е.</given-names></name><name xml:lang="ru"><surname>Топузов</surname><given-names>Э. Э.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Professor, Head Doctor</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор, главный врач</p></bio><email>lyalina@pasteurorg.ru</email><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Pasteur St. Petersburg Research Institute of Epidemiology and Microbiology</institution></aff><aff><institution xml:lang="ru">Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии имени Пастера</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Medical Information and Analytical Center</institution></aff><aff><institution xml:lang="ru">Медицинский информационно-аналитический центр</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Dermatovenerologic Dispensary № 8</institution></aff><aff><institution xml:lang="ru">Кожно-венерологический диспансер № 8</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">City Clinical Oncological Dispensary</institution></aff><aff><institution xml:lang="ru">Городской клинический онкологический диспансер</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-09-07" publication-format="electronic"><day>07</day><month>09</month><year>2022</year></pub-date><volume>39</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>144</fpage><lpage>154</lpage><history><date date-type="received" iso-8601-date="2022-09-07"><day>07</day><month>09</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-09-07"><day>07</day><month>09</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Lyalina L.V., Kholopov D.V., Khizha V.V., Kasatkin E.V., Topuzov Е.Е.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Лялина Л.В., Холопов Д.В., Хижа В.В., Касаткин Е.В., Топузов Э.Э.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Lyalina L.V., Kholopov D.V., Khizha V.V., Kasatkin E.V., Topuzov Е.Е.</copyright-holder><copyright-holder xml:lang="ru">Лялина Л.В., Холопов Д.В., Хижа В.В., Касаткин Е.В., Топузов Э.Э.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://permmedjournal.ru/PMJ/article/view/110826">https://permmedjournal.ru/PMJ/article/view/110826</self-uri><abstract xml:lang="en"><p><bold>Objective.</bold>To study the peculiarities of morbidity and mortality from malignant neoplasms associated with the human papillomavirus among male and female population in a megalopolis. The International Agency for Research on Cancer relates cancer of the oral cavity, tonsils and oropharynx, larynx, anal canal and skin of the perianal region, vulva, vagina, cervix and penis to malignant neoplasms associated with the human papillomavirus.</p> <p><bold>Material and methods.</bold> The analysis of morbidity and mortality was carried out according to the Population Cancer Registry of St. Petersburg for the period 2011–2020. The structure of the localization of the tumor process, trends and levels of morbidity and mortality from neoplasia associated with papillomavirus infection were studied. The study included information on 13,117 cases of the disease and 7,257 deaths.</p> <p>Research methods: epidemiological, clinical, statistical methods.</p> <p><bold>Results.</bold> Among all the malignant neoplasms, the proportion of HPV-associated neoplasias was 5.1 % in men and 5.8 % in women (<italic>p</italic> &lt; 0.05). In the structure of morbidity and mortality from HPV-associated tumors, cancer of the oral cavity and larynx occupies the largest share among men, and cervical cancer among women. The incidence of oropharyngeal cancer among the male population is higher compared to the female, the incidence of anal cancer among women is 2.9 times higher and there is an upward trend with higher growth rates (<italic>p</italic> &lt; 0.05).</p> <p><bold>Conclusions. </bold>The established gender differences of HPV-associated malignant neoplasms should be taken into account when justifying the directions for improving dispensary monitoring of patients and vaccination of papillomavirus infection.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Цель. </bold>Изучить особенности заболеваемости и смертности от злокачественных новообразований, ассоциированных с вирусом папилломы человека, мужского и женского населения в условиях мегаполиса. Международное агентство по изучению рака относит к злокачественным новообразованиям, ассоциированным с вирусом папилломы человека, рак полости рта, миндалин и ротоглотки, гортани, анального канала и кожи перианальной области, вульвы, влагалища, шейки матки и полового члена.</p> <p><bold>Материалы и методы.</bold> Анализ заболеваемости и смертности проведен по данным Популяционного ракового регистра Санкт-Петербурга за период 2011–2020 гг. Изучена структура по локализации опухолевого процесса, тенденции и уровни заболеваемости и смертности от неоплазий, ассоциированных с папилломавирусной инфекцией. В исследование включены сведения о 13 117 случаях заболевания и 7257 умерших.</p> <p>Методы исследования: эпидемиологический, клинический, методы статистики.</p> <p><bold>Результаты. </bold>Среди всех злокачественных новообразований доля ВПЧ-ассоциированных неоплазий составила у мужчин 5,1 %, у женщин – 5,8 % (<italic>р</italic> &lt; 0,05). В структуре заболеваемости и смертности от ВПЧ-ассоциированных опухолей среди мужчин наибольшую долю занимает рак полости рта и гортани, среди женщин – рак шейки матки. Заболеваемость орофарингеальным раком среди мужского населения выше по сравнению с женским, заболеваемость раком анального канала среди женщин выше в 2,9 раза, и имеет место тенденция к росту с более высокими темпами прироста (<italic>р</italic> &lt; 0,05).</p> <p><bold>Выводы. </bold>Установленные гендерные различия ВПЧ-ассоциированных злокачественных новообразований необходимо учитывать при обосновании направлений совершенствования диспансерного наблюдения за пациентами и вакцинопрофилактики папилломавирусной инфекции.</p></trans-abstract><kwd-group xml:lang="en"><kwd>malignant neoplasms associated with human papillomavirus</kwd><kwd>morbidity</kwd><kwd>mortality</kwd><kwd>gender differences</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>злокачественные новообразования</kwd><kwd>ассоциированные с вирусом папилломы человека</kwd><kwd>заболеваемость</kwd><kwd>смертность</kwd><kwd>гендерные различия</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Wild C.P., Weiderpass E., Stewart B.W., editors (2020). World Cancer Report: Cancer Research for Cancer Prevention. Lyon, France: International Agency for Research on Cancer, available at: http://www.publications.iarc.fr/586.</mixed-citation></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Bruni L., Albero G., Serrano B. et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report. 2022.</mixed-citation><mixed-citation xml:lang="ru">Bruni L., Albero G., Serrano B. et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 2022.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><mixed-citation>de Martel C., Plummer M., Vignat J. et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017; 141 (4): 664–670.</mixed-citation></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021; 71 (3): 209–249.</mixed-citation><mixed-citation xml:lang="ru">Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021; 71 (3): 209–249.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Gretsova O.P., Kostin A.A., Samsonov Yu.V. et al. Morbidity and mortality from malignant neoplasms associated with human papillomavirus. Research’n Practical Medicine Journal. 2017; 4 (3): 33–50 (in Russan).</mixed-citation><mixed-citation xml:lang="ru">Грецова О.П., Костин А.А., Самсонов Ю.В, и др. Заболеваемость и смертность от злокачественных новообразований, ассоциированных с вирусом папилломы человека. Research'n Practical Medicine Journal 2017; 4 (3): 33–50.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Kaprin A.D., Starinskii V.V., Shakhzadova A.O. Malignant neoplasms in Russia in 2020 (morbidity and mortality). Moscow: P. Hertsen MORI – branch of the FSBI NMRRC of the Ministry of Health of the Russian Federation 2021; 252 (in Russan).</mixed-citation><mixed-citation xml:lang="ru">Каприн А.Д., Старинский В.В., Шахзадова А.О. Злокачественные новообразования в России в 2020 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России 2021; 252.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><mixed-citation>Arbyn M., Weiderpass E., Bruni L. et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020; 8 (2): 191–203.</mixed-citation></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Vaginal cancer incidence statistics. Cancer Research UK. 2020, available at: https:// www.cancerresearchuk.org/health-professional/ cancer-statistics/statistics-by-cancer-type/vaginal-cancer/incidence#heading-One.</mixed-citation><mixed-citation xml:lang="ru">Vaginal cancer incidence statistics. Cancer Research UK. 2020, available at: https: //www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/ vaginal-cancer/incidence#heading-One.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><mixed-citation>Worldwide cancer data, 2020. World Cancer Research Fund International. 2020, available at: https://www.wcrf.org/dietandcancer/worldwide-cancer-data.</mixed-citation></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Heer E., Hackl M., Et M. et al. Trends in incidence of anal cancer in Austria, 1983–2016. Wien Klin Wochenschr. 2020; 132 (15): 438–443.</mixed-citation><mixed-citation xml:lang="ru">Heer E., Hackl M., Et M. et al. Trends in incidence of anal cancer in Austria, 1983–2016. Wien Klin Wochenschr 2020; 132 (15): 438–443.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><mixed-citation>Hansen B.T., Orumaa M., Lie A.K., Brennhovd B., Nygård M. Trends in incidence, mortality and survival of penile squamous cell carcinoma in Norway 1956–2015. Int J Cancer. 2018; 142 (8): 1586–1593.</mixed-citation></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Cancer Stat Facts: Oral Cavity and Pharynx Cancer. Surveillance, Epidemiology, and End Results Programe 18, 2010–2016. National Cancer Institute, 2018, available at: https://www. seer.cancer.gov/statfacts/html/oralcav.html.</mixed-citation><mixed-citation xml:lang="ru">Cancer Stat Facts: Oral Cavity and Pharynx Cancer. Surveillance, Epidemiology, and End Results Programe 18, 2010–2016. National Cancer Institute 2018, available at: https:// www.seer.cancer.gov/statfacts/html/oralcav.html.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Perea L.M., Estrada Peres M.A., Boing A. Fernando, et al. Trend of oral and pharyngeal cancer mortality in Brazil in the period of 2002 to 2013. Rev. Saúde Pública. 2018; 52.</mixed-citation><mixed-citation xml:lang="ru">Perea, L.M. Estrada, Peres M.A., Boing A. Fernando, et al. Trend of oral and pharyngeal cancer mortality in Brazil in the period of 2002 to 2013. Rev. Saúde Pública 2018; 52.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Nelson V.M., Benson A.B., 3rd. Epidemiology of Anal Canal Cancer. Surg Oncol Clin N Am. 2017; 26 (1): 9–15.</mixed-citation><mixed-citation xml:lang="ru">Nelson V.M., Benson A.B. Epidemiology of Anal Canal Cancer. Surg Oncol Clin N Am. 2017; 26 (1): 9–15.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Mensah F.A., Mehta M.R., Lewis J.S., Jr., et al. The human papillomavirus vaccine: current perspective and future role in prevention and treatment of anal Intraepithelial neoplasia and anal cancer. Oncologist. 2016; 21 (4): 453–460.</mixed-citation><mixed-citation xml:lang="ru">Mensah F.A., Mehta M.R., Lewis J.S., Jr., et al. The human papillomavirus vaccine: current perspective and future role in prevention and treatment of anal Intraepithelial neoplasia and anal cancer. Oncologist. 2016; 21 (4): 453–460.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Briko N.I., Lopukhov P.D., Kaprin A.D., et al. HPV-associated lesions in the Russian Federation: assessment of the problem. Journal of Modern Oncology. 2019; 21 (1): 45–50 (in Russan).</mixed-citation><mixed-citation xml:lang="ru">Лялина Л.В. Эпидемиологическое, социальное и экономическое обоснование вакцинации против папилломавирусной инфекции в Санкт-Петербурге. Инфекц. и иммунитет. 2014; 4 (2): 181–186.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Lyalina L.V. Epidemiological, social and economic evidences of vaccination against human papillomavirus infection in Saint-Petersburg. Infektsiya i immunitet = Russian Journal of Infection and Immunity. 2014; 4 (2): 181–186 (in Russan).</mixed-citation><mixed-citation xml:lang="ru">Брико Н.И., Лопухов П.Д., Каприн А.Д. и др. ВПЧ-ассоцированные поражения в Российской Федерации: оценка состояния проблемы. Современная онкология. 2019; 21 (1): 45–50.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
